Search research articles
Contact Us
Filters
Showing results (11-20 of 172) with videos related to
Page
of 18
Sort By:
Annals of Clinical Microbiology and Antimicrobials
|
March 10, 2005
Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis
Sanjay Sethi, Antonio Anzueto, David J Farrell
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
October 3, 2006
Disease severity in acute bacterial rhinosinusitis is greater in patients infected with Streptococcus pneumoniae than in those infected with Haemophilus influenzae
Michael Benninger, Itzhak Brook, David J Farrell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2011
Characterization of global patterns and the genetics of fusidic acid resistance
David J Farrell, Mariana Castanheira, Ian Chopra
Diagnostic Microbiology and Infectious Disease
|
January 13, 2009
Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired respiratory tract infections: the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study year 5 (2003-2004)
Francesco Blasi, David J Farrell, Luc Dubreuil
International Journal of Antimicrobial Agents
|
October 13, 2007
Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004)
Rafael Cantón, Serhat Unal, David J Farrell
Antimicrobial Agents and Chemotherapy
|
July 25, 2003
Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program
Ronald N Jones, David J Farrell, Ian Morrissey
Diagnostic Microbiology and Infectious Disease
|
October 14, 2018
In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States
David J Farrell, Rodrigo E Mendes, Mekki Bensaci
The Pediatric Infectious Disease Journal
|
January 30, 2007
Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States
David J Farrell, Keith P Klugman, Michael Pichichero
Journal of Clinical Microbiology
|
November 6, 2004
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study
Steven D Brown, David J Farrell, Ian Morrissey
Journal of Clinical Microbiology
|
November 10, 2006
Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study
David J Farrell, Thomas M File, Stephen G Jenkins
Page
of 18
Search research articles
Search
Showing results (11-20 of 172) with videos related to
Sort By:
Page
of 18
Annals of Clinical Microbiology and Antimicrobials
|
March 10, 2005
Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis
Sanjay Sethi, Antonio Anzueto, David J Farrell
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
October 3, 2006
Disease severity in acute bacterial rhinosinusitis is greater in patients infected with Streptococcus pneumoniae than in those infected with Haemophilus influenzae
Michael Benninger, Itzhak Brook, David J Farrell
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 7, 2011
Characterization of global patterns and the genetics of fusidic acid resistance
David J Farrell, Mariana Castanheira, Ian Chopra
Diagnostic Microbiology and Infectious Disease
|
January 13, 2009
Antibacterial activity of telithromycin and comparators against pathogens isolated from patients with community-acquired respiratory tract infections: the Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin study year 5 (2003-2004)
Francesco Blasi, David J Farrell, Luc Dubreuil
International Journal of Antimicrobial Agents
|
October 13, 2007
Antibacterial resistance patterns in Streptococcus pneumoniae isolated from elderly patients: PROTEKT years 1-5 (1999-2004)
Rafael Cantón, Serhat Unal, David J Farrell
Antimicrobial Agents and Chemotherapy
|
July 25, 2003
Quinupristin-dalfopristin resistance in Streptococcus pneumoniae: novel L22 ribosomal protein mutation in two clinical isolates from the SENTRY antimicrobial surveillance program
Ronald N Jones, David J Farrell, Ian Morrissey
Diagnostic Microbiology and Infectious Disease
|
October 14, 2018
In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States
David J Farrell, Rodrigo E Mendes, Mekki Bensaci
The Pediatric Infectious Disease Journal
|
January 30, 2007
Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States
David J Farrell, Keith P Klugman, Michael Pichichero
Journal of Clinical Microbiology
|
November 6, 2004
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study
Steven D Brown, David J Farrell, Ian Morrissey
Journal of Clinical Microbiology
|
November 10, 2006
Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study
David J Farrell, Thomas M File, Stephen G Jenkins
Page
of 18